These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 8725660)

  • 21. Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma.
    Sinicrope FA; Hart J; Michelassi F; Lee JJ
    Clin Cancer Res; 1995 Oct; 1(10):1103-10. PubMed ID: 9815900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bcl-2 protein expression is associated with p27 and p53 protein expressions and MIB-1 counts in breast cancer.
    Tsutsui S; Yasuda K; Suzuki K; Takeuchi H; Nishizaki T; Higashi H; Era S
    BMC Cancer; 2006 Jul; 6():187. PubMed ID: 16839413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Flow cytometry-pathology combined study of breast cancer].
    Yu ZY; Yu JM; Wu TH; Zhuo PY; Wang SF; Li M; Zhang X; Lü BY; Liu YB
    Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):420-2. PubMed ID: 16188128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apoptotic and mitotic indices predict survival rates in lymph node-negative colon carcinomas.
    Sinicrope FA; Hart J; Hsu HA; Lemoine M; Michelassi F; Stephens LC
    Clin Cancer Res; 1999 Jul; 5(7):1793-804. PubMed ID: 10430084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
    Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
    In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
    Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
    Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apoptosis in breast carcinomas detected with monoclonal antibody to single-stranded DNA: relation to bcl-2 expression, hormone receptors, and lymph node metastases.
    Frankfurt OS; Robb JA; Sugarbaker EV; Villa L
    Clin Cancer Res; 1997 Mar; 3(3):465-71. PubMed ID: 9815706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of Bcl-2 and p53 expression in primary breast tumors and corresponding metastatic lymph nodes.
    Arun B; Kilic G; Yen C; Foster B; Yardley D; Gaynor R; Ashfaq R
    Cancer; 2003 Dec; 98(12):2554-9. PubMed ID: 14669273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of the apoptotic markers in normal breast epithelium, benign mammary dysplasia and in breast cancer.
    Koda M; Kanczuga-Koda L; Reszec J; Sulkowska M; Famulski W; Baltaziak M; Kisielewski W; Sulkowski S
    Folia Morphol (Warsz); 2004 Aug; 63(3):337-41. PubMed ID: 15478112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up.
    el-Ahmady O; el-Salahy E; Mahmoud M; Wahab MA; Eissa S; Khalifa A
    Anticancer Res; 2002; 22(4):2493-9. PubMed ID: 12174951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bag-1 expression as a prognostic factor in tongue squamous cell carcinomas.
    Xie X; Clausen OP; Boysen M
    Laryngoscope; 2004 Oct; 114(10):1785-90. PubMed ID: 15454773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microvessel density, proliferating activity, p53 and bcl-2 expression in in situ ductal carcinoma of the breast.
    Zolota V; Gerokosta A; Melachrinou M; Kominea A; Aletra C; Scopa CD
    Anticancer Res; 1999; 19(4B):3269-74. PubMed ID: 10652623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between the expression of apoptosis-related bcl-2 and p53 oncoproteins and the carcinogenesis and progression of breast carcinomas.
    Zhang GJ; Kimijima I; Abe R; Kanno M; Katagata N; Hara K; Watanabe T; Tsuchiya A
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2329-35. PubMed ID: 9815631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apoptosis loss and bcl-2 expression: key determinants of lymph node metastases in T1 breast cancer.
    Sierra A; Castellsagué X; Tórtola S; Escobedo A; Lloveras B; Peinado MA; Moreno A; Fabra A
    Clin Cancer Res; 1996 Nov; 2(11):1887-94. PubMed ID: 9816145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
    D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
    Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytological grading, apoptosis, and Bcl-2 protein expression in breast cancer.
    Hemachandran M; Nijhawan R; Joshi K
    Diagn Cytopathol; 2002 Jun; 26(6):356-9. PubMed ID: 12112824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low expression of bcl-2 in Brca1-associated breast cancers.
    Freneaux P; Stoppa-Lyonnet D; Mouret E; Kambouchner M; Nicolas A; Zafrani B; Vincent-Salomon A; Fourquet A; Magdelenat H; Sastre-Garau X
    Br J Cancer; 2000 Nov; 83(10):1318-22. PubMed ID: 11044356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expressions of cyclin D1, p53, bcl-2, and bax in infiltrative ductal carcinoma of the breast: correlations with clinicopathologic characteristics.
    Arýkök AT; Onal BU; Han U
    Breast J; 2006; 12(4):391-2. PubMed ID: 16848860
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunohistochemical evaluation of cyclin D1 in breast cancer.
    Bilalović N; Vranić S; Basić H; Tatarević A; Selak I
    Croat Med J; 2005 Jun; 46(3):382-8. PubMed ID: 15861516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of proliferation activity in breast carcinoma by flow cytometry analysis of S-phase and quantitative analysis of MIB-1.
    Masood S; Bui MM; Lu L
    Ann Clin Lab Sci; 1998; 28(6):315-23. PubMed ID: 9846198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.